MYX receives purported termination notice from Cosette
Filed with ASX · · 1 page · English
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call10 December 2025, Adelaide, Australia: Mayne Pharma Group Limited (ASX: MYX) (Mayne Pharma) refers to its announcement on 21 November 2025 regarding the FIRB condition precedent and a notice received from Cosette Pharmaceuticals, Inc. (Cosette) notifying Mayne Pharma of the failure to satisfy the FIRB condition precedent and requiring the parties to consult in good faith under clause 3.7(a)(ii) of
Mayne Pharma Group Ltd. on 6ix
Story so far
Earlier from Mayne Pharma
- Mayne Pharma issues notice of intention to terminate the SID
- Update on FIRB condition and scheme
- Trading Halt
- Pause in Trading
- Update on status of FIRB approval and second court hearing
Later from Mayne Pharma
- Mayne Pharma terminates Scheme Implementation Deed
- Termination of Proposed Acquisition of Mayne Pharma
- Market Update
- 2025 AGM presentation and business update
- MYX to claim against Cosette, Avista & Mr David Burgstahler
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma